FDA Drug Application (022193) for NAVSTEL by ALCON PHARMS LTD

Back to FDA Applications sponsored by ALCON PHARMS LTD

Application Number022193
Product Number001
FormSOLUTION;IRRIGATION
Dosage0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNAVSTEL
Active IngredientCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient CALCIUM CHLORIDE112
List of drugs with Active Ingredient DEXTROSE323
List of drugs with Active Ingredient MAGNESIUM CHLORIDE138
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient SODIUM BICARBONATE53
List of drugs with Active Ingredient SODIUM CHLORIDE352
List of drugs with Active Ingredient SODIUM PHOSPHATE7


Back to FDA Applications sponsored by ALCON PHARMS LTD